Evidence map›Paper›PMID 30047288›Full record

ReviewThe Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry2019

New Insights into the Neurobiology of Restless Legs Syndrome.

Sergi Ferré, Diego García-Borreguero, Richard P Allen, Christopher J Earley

Abstract readReview
In one paragraph

Review in The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. A Randomized, Placebo-Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome.Movement disorders : official journal of the Movement Disorder Society · 2021
    Trial
  6. Trial
  7. Review
  8. Altered iron metabolism and iron therapy in restless legs syndrome.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  9. Article
  10. Review
  11. Adenosine ABiomolecules & therapeutics · 2026
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Sleep-related movement disorders in children: recent updates.World journal of pediatrics : WJP · 2025
    Review
  18. Update on sleep disorders in advanced Parkinson's disease: a narrative review.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  19. Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sergi Ferré1 National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.ORCID 0000-0002-1747-1779
Diego García-Borreguero2 Sleep Research Institute, Madrid, Spain.
Richard P Allen3 Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
Christopher J Earley3 Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.

Funding

Neurotransmitter Receptor Heteromers in the Striatal Spine ModuleZIADA000493 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI FERRE, SERGI · 2009 to 2025
$35.6M
Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

Restless legs syndrome (RLS) is a common sensorimotor disorder, whose basic components include a sensory experience, akathisia, and a sleep-related motor sign, periodic leg movements during sleep (PLMS), both associated with an enhancement of the individual's arousal state. The present review attempts to integrate the major clinical and experimental neurobiological findings into a heuristic pathogenetic model. The model also integrates the recent findings on RLS genetics indicating that RLS has aspects of a genetically moderated neurodevelopmental disorder involving mainly the cortico-striatal-thalamic-cortical circuits. Brain iron deficiency (BID) remains the key initial pathobiological factor and relates to alterations of iron acquisition by the brain, also moderated by genetic factors. Experimental evidence indicates that BID leads to a hyperdopaminergic and hyperglutamatergic states that determine the dysfunction of cortico-striatal-thalamic-cortical circuits in genetically vulnerable individuals. However, the enhanced arousal mechanisms critical to RLS are better explained by functional changes of the ascending arousal systems. Recent experimental and clinical studies suggest that a BID-induced hypoadenosinergic state provides the link for a putative unified pathophysiological mechanism for sensorimotor signs of RLS and the enhanced arousal state.

Indexed as

AdenosineAnimalsBrainDopamineGlutamic AcidHomeostasisHumansIronNeuronsRestless Legs SyndromeSpinal CordAdenosineDopamineGlutamic AcidIronadenosinearousalbrain iron deficiencydopamineglutamaterestless legs syndrome

Identifiers

PMID30047288
PMCPMC9372713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.